|
Market Closed -
Other stock markets
|
After hours 06:11:29 pm | |||
| 25.01 USD | +0.40% |
|
25.10 | +0.36% |
| Jul. 30 | Pfizer to Proceed With Regulatory Filings for Litfulo in Nonsegmental Vitiligo | MT |
| Jul. 30 | Bristol Myers raises 2026 forecast as Eliquis, newer medicines power results | RE |
| Market Cap | 142B 123B 115B 105B 199B 13,541B 202B 1,351B 530B 6,745B 533B 521B 22,347B | P/E 2026 * |
12.6x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 191B 166B 154B 142B 268B 18,250B 273B 1,821B 714B 9,090B 719B 703B 30,116B | EV / Sales 2026 * |
3.1x | EV / Sales 2027 * | 3.12x |
| Free-Float |
59.05% | Yield 2026 * |
6.91% | Yield 2027 * | 6.98% |
Last Transcript: Pfizer Inc.
| 1 day | +0.36% | ||
| Current month | +3.86% | ||
| 1 month | +3.86% | ||
| 3 months | -6.33% | ||
| 6 months | -5.41% | ||
| Current year | +0.44% |
| 1 week | 24.44 |  | 25.5 |
| 1 month | 23.62 | | 25.65 |
| Current year | 23.62 | | 28.74 |
| 1 year | 23.11 | | 28.74 |
| 3 years | 20.92 | | 37.19 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
David Denton
DFI | Director of Finance/CFO | 60 | 2022-05-01 |
| Chief Tech/Sci/R&D Officer | - | 2006-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 | Free | Chief Executive Officer | 24 | 0.0000% | ||
| 7/9/26 | Free | Chief Executive Officer | 84 | 0.0000% | ||
| 6/30/26 | Free | Chief Executive Officer | 25 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | -.--% | +5.04% | -30.66% | 142B | |
| -0.53% | -3.12% | +51.15% | +150.58% | 1,030B | |
| +0.21% | -1.13% | +53.26% | +46.92% | 617B | |
| -2.51% | -2.33% | +32.56% | +66.35% | 455B | |
| +0.06% | +1.17% | +36.21% | +31.25% | 350B | |
| -0.14% | -0.83% | +33.24% | +40.28% | 299B | |
| -0.69% | -0.44% | +9.86% | +14.23% | 265B | |
| -7.37% | -4.31% | -5.69% | -41.99% | 225B | |
| -0.64% | +3.68% | +27.80% | +62.95% | 209B | |
| -0.82% | -0.50% | +13.46% | +69.41% | 163B | |
| Average | -1.03% | +4.47% | +25.69% | +40.93% | 375.46B | |
| Weighted average by Cap. | -0.60% | +4.73% | +35.42% | +67.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.74B 53.56B 49.85B 45.8B 86.55B 5,889B 87.94B 588B 231B 2,933B 232B 227B 9,718B | 59.37B 51.5B 47.93B 44.04B 83.21B 5,662B 84.56B 565B 222B 2,820B 223B 218B 9,344B |
| Net income | 10.63B 9.22B 8.59B 7.89B 14.9B 1,014B 15.14B 101B 39.7B 505B 39.93B 39.05B 1,674B | 10.28B 8.92B 8.3B 7.63B 14.41B 980B 14.64B 97.83B 38.38B 488B 38.6B 37.76B 1,618B |
| Net Debt | 49.36B 42.82B 39.86B 36.62B 69.19B 4,708B 70.31B 470B 184B 2,345B 185B 181B 7,770B | 43.17B 37.44B 34.85B 32.02B 60.51B 4,117B 61.48B 411B 161B 2,051B 162B 159B 6,794B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | $25.01 | +0.40% | 43,513,061 |
| 26-07-30 | $24.91 | -0.95% | 44,954,469 |
| 26-07-29 | $25.15 | -0.40% | 30,394,967 |
| 26-07-28 | $25.25 | +2.35% | 49,942,743 |
| 26-07-27 | $24.67 | +0.53% | 38,355,183 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
